Home › Funds › Bleichroeder LP › IMMX
Bleichroeder LP position in IMMX
IMMIX BIOPHARMA INC · Health Care
Bleichroeder LP reported holding 1,000,000 shares of IMMX (IMMIX BIOPHARMA INC) in its Q3 2026 13F filing — a position valued at US$10.4M, representing 1.05% of its reported portfolio and ranking #37 among its reported holdings. Bleichroeder LP has disclosed IMMX holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Bleichroeder LP's IMMX position evolved
Bleichroeder LP first disclosed a stake in IMMX in Q1 2024 at 850,000 shares (US$2.6M). The position peaked in Q3 2026 at 1,000,000 shares, worth US$10.4M. Across 11 filings, Bleichroeder LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 9 time(s). The most recent filing (Q3 2026) shows 1,000,000 shares valued at US$10.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 850.00K | $2.61M | New |
| Q2 2024 | 850.00K | $1.68M | Hold |
| Q3 2024 | 850.00K | $1.27M | Hold |
| Q4 2024 | 850.00K | $1.87M | Hold |
| Q1 2025 | 850.00K | $1.43M | Hold |
| Q2 2025 | 850.00K | $1.76M | Hold |
| Q3 2025 | 850.00K | $1.78M | Hold |
| Q4 2025 | 1.00M | $5.23M | Add |
| Q1 2026 | 1.00M | $9.11M | Hold |
| Q2 2026 | 1.00M | $10.31M | Hold |
| Q3 2026 | 1.00M | $10.40M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMMX and 13F data
IMMX (IMMIX BIOPHARMA INC) is a Health Care company. 95 other funds we track also report a position in IMMX — the largest reported positions include Saturn V Capital Management LP (US$48.0M), Deep Track Capital, LP (US$28.6M), Opaleye Management Inc. (US$24.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMMX
- Saturn V Capital Management LP 4.66M sh · $48.03M · Q2 2026
- Deep Track Capital, LP 2.77M sh · $28.61M · Q2 2026
- Opaleye Management Inc. 2.35M sh · $24.18M · Q2 2026
- GREAT POINT PARTNERS LLC 1.28M sh · $13.17M · Q2 2026
- Velan Capital Investment Management LP 1.08M sh · $11.19M · Q2 2026
- Logos Global Management LP 1.00M sh · $10.31M · Q2 2026
- Blue Owl Capital Holdings LP 602.05K sh · $6.26M · Q3 2026
- Monashee Investment Management LLC 450.00K sh · $4.68M · Q3 2026
- KVP Capital Advisors, LP 230.42K sh · $2.38M · Q2 2026
- Imprint Wealth LLC 26.23K sh · $270.46K · Q2 2026
More on Bleichroeder LP
FAQ
How long has Bleichroeder LP held IMMX?
Bleichroeder LP has disclosed IMMX holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is Bleichroeder LP's current position in IMMX?
As of Q3 2026, Bleichroeder LP holds 1.00M shares of IMMX (IMMIX BIOPHARMA INC), valued at $10.40M, representing 1.05% of its reported portfolio and ranking #37.
Has Bleichroeder LP been buying or selling IMMX?
In the latest 13F filing (Q3 2026), Bleichroeder LP held unchanged its position in IMMX. The position peaked in Q3 2026 at 1.00M shares.
Which other funds hold IMMX?
Other major institutional holders of IMMX include Saturn V Capital Management LP, Deep Track Capital, LP, Opaleye Management Inc., among 95 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.